ARCHIVES

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

Parkinson Heads Oncology At Amgen

May 2, 2003

New Agent Targets Glioma Tumor Cells Prior To Surgery

May 30, 2003

FDA Caps Advisors’ Holdings To $50,000 In Firms Affected By Committee Meetings.

August 8, 2008

Lung, Head & Neck Treatment Advances Reported At ASCO Annual Meeting

May 27, 1977

Abstracts Of Papers Presented By Breast Cancer Task Force

August 27, 1976

In Brief: Basic Science Center Funding Plan Clarified; Janice Feldman Leaves As Chief Of NIH Nursing

February 17, 1989